Moody’s affirms “MIG 2” for Yukon-Kuskokwim Health Corp

Moody’s Investors Service has affirmed its “MIG 2” rating for Bethel, Alaska-based Yukon-Kuskokwim Health Corp, affecting $162 million of loan anticipation revenue notes.

Advertisement

The rating reflects a commitment from the U.S. Department of Agriculture to provide a direct loan upon completion of the system’s construction project to pay its Series 2017 notes prior to maturity on Dec. 1, 2020.

The rating incorporates the system’s multiphase approach to completing the project with an experienced construction team and ample time between the project completion date and note maturity.

More articles on healthcare finance:

HCA ups debt sale to $1.5B
2 California hospitals face closure if sale delayed
Vermont hospital backtracks on questionable bills

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.